|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 89.00 INR | +1.42% |
|
-7.44% | -19.16% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||
Drugs And Chemicals | 30Cr | 59Cr | 62Cr | 83Cr | 103.97Cr | |
Total Assets | 18Cr | 35Cr | 47Cr | 59Cr | 121.65Cr | |
Interest Expense | -28.57L | -26.55L | -51.97L | -72.66L | -84.3L | |
Income Tax Expense | 19.33L | 1.62Cr | 1.93Cr | 4.35Cr | 5.12Cr | |
CAPEX | - | -1.93Cr | -3.07Cr | -93.99L | -3.47Cr | |
EBT | 84.79L | 5.79Cr | 6.96Cr | 14Cr | 19Cr | |
D&A | 39.38L | 46.03L | 54.98L | 56.78L | 63.6L | |
Net Income | 65.47L | 4.17Cr | 5.03Cr | 10Cr | 14Cr |
Geographical Revenue Distribution History
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
India | 30Cr | 59Cr | 62Cr | 83Cr | 103.97Cr | |
Total Assets | 18Cr | 35Cr | 47Cr | 59Cr | 121.65Cr | |
Interest Expense | -28.57L | -26.55L | -51.97L | -72.66L | -84.3L | |
Income Tax Expense | 19.33L | 1.62Cr | 1.93Cr | 4.35Cr | 5.12Cr | |
D&A | 39.38L | 46.03L | 54.98L | 56.78L | 63.6L | |
CAPEX | - | -1.93Cr | -3.07Cr | -93.99L | -3.47Cr | |
Net Income | 65.47L | 4.17Cr | 5.03Cr | 10Cr | 14Cr | |
EBT | 84.79L | 5.79Cr | 6.96Cr | 14Cr | 19Cr |
- Stock Market
- Stocks
- QUESTLAB Stock
- Financials Quest Laboratories Limited
- Business Segments
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
